Broad New China Policies Aim To Improve Market Access

Expanded Exclusivity Among Proposals

China's policy measures to support innovative drugs development
Collaborative learning method will likely provide a solution for data collaboration among R&D, the clinic and payment system sides amid these entities’ coopetition. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from China

More from Market Access